Thursday, September 18, 2025

Latest

MediPharm Labs Posts Revenues Of $5.5 Million, Net Loss Of $13.9 Million

MediPharm Labs (TSX: LABS) this morning continued its recent trend of dismal financing results, posting revenues of just $5.5 million for the period ended March 31, 2021, along with a net loss of $13.9 million for the three month period.

Revenues were down 9.9% on a quarter over quarter basis from the $6.1 million in revenues the company posted for the fourth quarter of 2020. The company blamed the decline of “challenging operating conditions” within the domestic Canadian retail cannabis market, and reduced purchasing from provincial regulators. Recreational sales declined 40% quarter over quarter to $3.4 million, while international sales grew to $2.1 million.

Things didn’t get better from here, with cost of sales coming in at $6.2 million, resulting in a negative gross profit of $0.7 million. Operating expenses continued this trend, with the company posting an operating loss of $7.9 million. The largest expenses here consisted of G&A expenditures of $4.0 million, as well as marketing and selling expenses of $1.3 million.

After a final finance expense of $9.7 million which was partially offset by an unrealized gain in derivates to the tune of $3.7 million, the company posted an overall net loss of $13.9 million.

The company has yet to name a new CEO following the stepping down of Pat McCutcheon late last year, with the company simply stating that several candidates have been identified.

MediPharm Labs last traded at $0.40 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

Why $10K Gold No Longer Sounds Crazy | Dan Wilton – First Mining Gold

The Pure Silver Set Up! | Joaquin Marias – Argenta Silver Corp

Why $30,000 Gold Isn’t Crazy! | Simon Marcotte – Northern Superior

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Medipharm Labs Posts Revenues of $13.9 Million, Net Loss of $3.5 Million For Q2 2020

Medipharm Labs (TSX: LABS) reported further disappointing quarterly results this morning, with revenues of $13.9...

Thursday, August 13, 2020, 09:25:18 AM

Medipharm Labs Delays Q1 Financials, Announces Inventory Impairments

Medipharm Labs (TSX: LABS) this morning announced that it will be delaying its first quarter...

Thursday, May 14, 2020, 08:30:28 AM

Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role, Remain As Chairman

Medipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the...

Thursday, December 10, 2020, 07:38:42 AM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM

Is The Medipharm Labs Supply Arrangement The Source Of Cronos’ Late Filings?

Earlier this week, Cronos Group (TSX: CRON) (NASDAQ: CRON) quietly announced that they would delay...

Wednesday, March 4, 2020, 12:12:37 PM